Major Cause of Drug-resistance in Prostate Cancer Patients Identified

News   Aug 15, 2017 | Original story from Mayo Clinic

 
Major Cause of Drug-resistance in Prostate Cancer Patients Identified

Mutations in the SPOP gene (depicted on the left) can be used to guide administration of anti-cancer drugs (labeled treatment A through D below) in patients with prostate cancer. Credit: Mayo Clinic

 
 
 

RELATED ARTICLES

Antimalarial Drugs Could Offer Clinical Benefit to Cancer Patients

News

Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.

READ MORE

Improving Poultry Production Through Precision Fertility Management

News

Whilst the poultry industry has historically regarded fertility as a physiological problem of some males, on-going research is revealing that this view is misleadingly simplistic. The reality is that variation in fertility is a complex issue because fertility is determined by the interaction of male and female factors at multiple levels.

READ MORE

Radiographs of Dolly's Skeleton Show No Signs of Abnormal Osteoarthritis

News

Original concerns that cloning caused early-onset osteoarthritis (OA) in Dolly the sheep are unfounded, say experts at the University of Nottingham and the University of Glasgow.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE